Vitex Pharmaceuticals

End-to-end contract development and manufacturing for complementary medicines on Australia’s shores, integrating formulation science, regulatory planning, analytical testing, manufacturing, packaging and supply-chain management within a single platform. This cohesive model accelerates product-to-market while upholding rigorous quality standards and regulatory compliance.

Key capabilities include:

• Product development and formulation with access to R&D laboratories, pilot-scale facilities, and stability data to de-risk launches and inform end-to-end design.
• Regulatory support covering ARTG listings, export certification, and Halal accreditation to streamline market-entry in domestic and international markets, with ongoing compliance guidance.
• Analytical services via an in-house GMP laboratory for method development, chemical and microbiological testing, stability studies and data reporting aligned to regulatory requirements.
• Manufacturing and private label featuring blending, dry granulation/roller compaction, fluid-bed drying, milling, compression and film coating, plus packaging, labeling and secondary packaging options.
• Global supply chain management ensuring inventory control, demand planning and on-time delivery across markets, with end-to-end logistics coordination.

Located in the Sydney region, the Eastern Creek campus provides robust onshore manufacturing capabilities. The group has expanded with a modern Wonderland facility in Western Sydney—a $250 million investment creating up to 800 jobs—to boost capacity and support international export (spanning 26 countries) from an Australian base.

Distinctive value arises from a quality-led, regulator-ready platform backed by a long heritage, a 100% Australian-owned operation, and scale that enables private-label partnerships, multiple dosage formats, and comprehensive packaging options. This combination supports brands seeking reliable, compliant Australian-made products from concept to shelf.